Skip to main content
OpenTrials

Clinical trial condition

Varicella Zoster Virus Infection

Explore clinical trials studying Varicella Zoster Virus Infection. Study availability and eligibility vary by location and protocol.

340 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Varicella Zoster Virus Infection trial results

Completed

Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years

NCT04869982

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Huaian, Jiangsu, China
  • GSK Investigational Site Lianyungang, China
  • GSK Investigational Site Shanghai, China
  • GSK Investigational Site Shanghai, China
View Trial Details
Completed

Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine

NCT03894969

Conditions
Chronic Disease, DNA Virus Infections, Disease Attributes, +13 more
Locations
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tartu, Estonia
  • GSK Investigational Site Tartu, Estonia
  • GSK Investigational Site Helsinki, Finland
View all 14 locations
View Trial Details
Completed

Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older

NCT02735915

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Hradec Králové, Czechia
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Würzburg, Bavaria, Germany
  • GSK Investigational Site Essen, North Rhine-Westphalia, Germany
View Trial Details

Related conditions